Expert Perspectives on NIPT

Slides:



Advertisements
Similar presentations
NON – INVASIVE PRENATAL TESTING
Advertisements

© 2009 NHS National Genetics Education and Development CentreGenetics and Genomics for Healthcare This PowerPoint file contains.
Antenatal Screening Dr Emma Parry CMFM
Polymorphism & Restriction Fragment Length Polymorphism (RFLP)
Prevention of Birth Defects An Overview of Primary and Secondary Strategies.
About these slides Provided by the CAP as an aid to pathologists to facilitate discussion on the topic. Content has been reviewed by experts at the CAP,
Non-Invasive Prenatal Testing (NIPT)
Non-Invasive Prenatal Testing
NON – INVASIVE PRENATAL TESTING
Trait and Sex Selection: The Arrival of Non-Invasive Prenatal Genetic Testing Jaime King, JD, PhD University of California, Hastings College of the Law.
Prenatal Genetic Testing for Chromosomal Anomalies By: Linda DeFranco.
Enhanced Prenatal Screening Program
IN THE NAME OF GOD. CRITICALLY APPRAISED TOPIC If there is a Non-invasive prenatal testing for aneuploidies with low FPR at first trimester? If we can.
Ultrasound imaging.
Max Brinsmead MB BS PhD November  Some 1- 2% of babies will have a major disability that dates from the prenatal period  Either  Chromosomal.
Contemporary Prenatal Diagnosis – The Clinician’s Perspective
New Follow-up Service Introduced by the California Prenatal Screening Program Non-Invasive Prenatal Testing (NIPT, NPT) NIPT: Non-invasive prenatal testing.
TEMPLATE DESIGN © Retrospective Analysis of Amniocentesis in UKMMC ZulidaR, MAJamil Universiti Putra Malaysia, UPM Serdang,
First Trimester Screening
Advanced maternal age & pregnancy By Dr. Khattab KAEO Prof. & Head of Obstetrics and Gynaecology Depatment Faculty of Medicine, Al-Azhar University, Damietta.
An Ounce of Prevention  2000, 2005, 2011 The Curators of the University of Missouri Preconception Planning and Monitoring Fetal Health Twenty Questions.
MQlicker This session will utilise the mQlicker interactive audience program Questions will be presented and you will be able to respond electronically.
Prenatal Diagnosis of Congenital Malformations for Undergraduates
BIOE 301 Lecture Thirteen. Review of Lecture 12 The burden of cancer Contrasts between developed/developing world How does cancer develop? Cell transformation.
1.
The Role of Prenatal screening as part of Routine Obstetric Care
Non-Invasive Prenatal Testing (NIPT)
Erika Castro, PGY 3 Cook County-Loyola-Provident Family Medicine Residency 2/27/2014 PRENATAL SCREENING AND DIAGNOSIS COUNSELING
Dr Shuhaila Ahmad Associate Professor FetoMaternal Unit UKMMC.
Genetic Testing in Pregnancy Lisbeth M. Lazaron, MD March 2013.
Non-invasive Prenatal Testing
Leah Pinckney DOWN SYNDROME.  What is Down Syndrome?  A genetic disorder caused by abnormal cell division that results in an extra chromosome.  “Trisomy.
Prenatal Screening and Diagnosis. What is Prenatal Diagnosis?  In-utero detection of fetal anomalies General population risk is 3-5% for any birth defect.
Prenatal Approach (Chromosomal) Shahram Savad MD, Medical Genetics.
a systematic review and meta-analysis
In The Name Of God. In The Name Of God Prenatal Diagnosis of Congenital Disorders Dr. Gita Hatamizadeh OBGYN- Infertility Fellowship Assisted professor.
Single-Stranded DNA Library Preparation Preferentially Enriches Short Maternal DNA in Maternal Plasma J.S.L. Vong, J.C.H. Tsang, P. Jiang, W.-S. Lee, T.Y.
بنام خدا.
KnowDNA Innovating Prenatal Testing.
Antenatal Screening Rebecca Sykes.
Karyotyping  .
Jeffrey A. Kuller, MD; Sean C. Blackwell, MD
Silent No More:.
WHY GENETIC COUNSELING IS IMPORTANT
MarketsandMarkets Presents Find out How the Value of Non Invasive Prenatal Testing Market has changed over Time html.
MarketsandMarkets Presents Non Invasive Prenatal Testing Market by Consumables Market Size, By Type, 2016 vs html.
MarketsandMarkets Presents Non-invasive Prenatal Testing (NIPT) Market size and trend during the Forecast Period Next Five years html.
MarketsandMarkets Presents Non Invasive Prenatal Testing (NIPT) Market Size, By Application and Forecast html.
MarketsandMarkets Presents Non Invasive Prenatal Testing (NIPT) Market Launch of New and Advanced Products html.
MarketsandMarkets Presents Non Invasive Prenatal Testing (NIPT) Market: intelligence, strategy & Global Forecast html.
MarketsandMarkets Presents Non Invasive Prenatal Testing (NIPT) Market: NGS Systems to Register the Highest CAGR in the NIPT Instruments Market from 2016.
MarketsandMarkets Presents Non Invasive Prenatal Testing (NIPT) Market is expected to reach $2.88 Billion by 2021 at a CAGR of 16.4% html.
MarketsandMarkets Presents Non Invasive Prenatal Testing (NIPT) Market worth $2.88 Billion by html.
UOG Journal Club: April 2017
Reassurance and Anxiety Reduction Meaningful Informed Decision Making
Non Invasive Prenatal Testing for Aneuploidy (NIPT)
breast cancer 2, early onset What does this protein make up or do?
Introduction to prenatal diagnosis
UOG Journal Club: August 2018
Revealing Characteristics of Patients at High Risk for Developing Atrial Fibrillation.
Genetic Testing.
Prenatal testing.
غربالگری ناهنجاریهای جنین
A novel counting algorithm to detect common fetal trisomies
Ultrasonography or venography for the diagnosis of TIPS malfunction?
Prenatal Screening for Genetic Conditions
Following screening, genetic testing can occur during pregnancy for Down syndrome, Trisomy 18, and other conditions. Two major types of genetic testing.
NON – INVASIVE PRENATAL TESTING
Dr Huda Muhaddein Muhammad
Nuchal translucency screening uses ultrasound to screen for Down syndrome, other conditions caused by an extra chromosome (trisomy 13 and 18), and congenital.
Presentation transcript:

Expert Perspectives on NIPT

Definition of Aneuploidy

Cell-Free DNA

Mosaicism

Risk of DS or Any Chromosomal Abnormality

Value of NIPT

Alternatives to NIPT

Detection Rates of DS Using Various Screening Modalities

False Positive Rates Using Various Screening Modalities

Causes of False Positive Rates in NIPT

Clinical Utility of NIPT PPV

NIPT Performance Characteristics PPV

Pretest Counseling General Overview

Pretest Counseling NIPT

Causes of No-Call Results in NIPT

Causes of Low Fetal Fraction

Managing Patients With Low Fetal Fraction

Incidence of Chromosomal Abnormalities

NIPT Performance Characteristics

Other Information Provided by NIPT

Conditions Not Detected in NIPT

Value of Offering NIPT Patients an Early Ultrasound at 12 to 14 Weeks

Conclusions

Abbreviations